BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tendilla-Beltrán H, Sanchez-Islas NDC, Marina-Ramos M, Leza JC, Flores G. The prefrontal cortex as a target for atypical antipsychotics in schizophrenia, lessons of neurodevelopmental animal models. Prog Neurobiol 2021;199:101967. [PMID: 33271238 DOI: 10.1016/j.pneurobio.2020.101967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Amani P, Habibpour R, Karami L. Characterizing aripiprazole and its ester derivatives, lauroxil and cavoxil, in interaction with dopamine D2 receptor: Molecular docking and dynamics simulations with physicochemical appraisals. Journal of Molecular Liquids 2022;362:119787. [DOI: 10.1016/j.molliq.2022.119787] [Reference Citation Analysis]
2 Fišar Z. Biological hypotheses, risk factors, and biomarkers of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2022;:110626. [PMID: 36055561 DOI: 10.1016/j.pnpbp.2022.110626] [Reference Citation Analysis]
3 Rehman S, Nabi B, Javed A, Khan T, Iqubal A, Ansari MJ, Baboota S, Ali J. Unraveling enhanced brain delivery of paliperidone-loaded lipid nanoconstructs: pharmacokinetic, behavioral, biochemical, and histological aspects. Drug Deliv 2022;29:1409-22. [PMID: 35532148 DOI: 10.1080/10717544.2022.2069880] [Reference Citation Analysis]
4 Tendilla-Beltrán H, Coatl-Cuaya H, Meneses-Prado S, Vázquez-Roque RA, Brambila E, Tapia-Rodríguez M, Martín-Hernández D, Garcés-Ramírez L, Madrigal JLM, Leza JC, Flores G. Neuroplasticity and inflammatory alterations in the nucleus accumbens are corrected after risperidone treatment in a schizophrenia-related developmental model in rats. Schizophr Res 2021;235:17-28. [PMID: 34298239 DOI: 10.1016/j.schres.2021.07.014] [Reference Citation Analysis]
5 Burstein ES. Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for Pharmacotherapy. CNS Drugs 2021;35:727-41. [PMID: 34224112 DOI: 10.1007/s40263-021-00836-7] [Reference Citation Analysis]
6 Rivas-Ramírez ÁR, Tendilla-Beltrán H, Gómez-Mendoza LE, Loaiza G, Flores G. Patients with schizophrenia have decreased COVID-19 prevalence among hospitalised patients with psychiatric and neurological diseases: A retrospective analysis in Mexican population. Int J Clin Pract 2021;:e14528. [PMID: 34125988 DOI: 10.1111/ijcp.14528] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Tendilla-Beltrán H, Flores G. Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19. Gen Hosp Psychiatry 2021;71:137-9. [PMID: 34045093 DOI: 10.1016/j.genhosppsych.2021.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chamera K, Trojan E, Kotarska K, Szuster-Głuszczak M, Bryniarska N, Tylek K, Basta-Kaim A. Role of Polyinosinic:Polycytidylic Acid-Induced Maternal Immune Activation and Subsequent Immune Challenge in the Behaviour and Microglial Cell Trajectory in Adult Offspring: A Study of the Neurodevelopmental Model of Schizophrenia. Int J Mol Sci 2021;22:1558. [PMID: 33557113 DOI: 10.3390/ijms22041558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]